Financial Daily from THE HINDU group of publications
Tuesday, May 07, 2002

News
Features
Stocks
Port Info
Archives

Group Sites

Industry & Economy - Medical & Surgical Equipments


Brand scheme scrapping irks medical devices industry

P.T. Jyothi Datta

NEW DELHI, May 6

THE domestic medical devices industry fears that its exports would see a negative growth this year, following the scrapping of the brand-promotion scheme in this year's Exim Policy.

Faced with competitive generic products from the Chinese and Korean markets, the nascent domestic segment comprising over 100 manufacturers, has urged the Union Commerce Ministry to either revoke the scrapping of the scheme — where the manufacturers could avail 20 per cent DEPB benefit on the product group — or provide an alternate buffer.

Since it is unlikely that the brand promotion scheme would be brought back, alternatively the industry has sought a review of the value cap of Rs 55 per kg to Rs 1,950 per kg or the equivalent to DEPB of 17 per cent.

"The earlier value cap represented only the value of the plastic used in the medical product and not the complete sterile medical device which consists of steel/rubber and other value added components," the All India Syringes and Needles Manufacturers' Association said in its representation to the Union Commerce Minister.

The association comprises makers of disposable and auto-disposable syringes, disposable needles, non-pyrogenic sterile intravenous infusion set components and surgical blades.

Mr Pardeep Sareen, representative with the Hindustan Syringes and Medical Devices Ltd (HMD), told Business Line that the industry feared a de-growth of 63 per cent in this year's exports, as a result of scrapping the brand-promotion scheme.

HMD are the makers of the popular medical devices brands such as Dispovan, Scalpvan, Cathula, Unolok and Vaku8, which get exported under the same names.

In 1999, when the average price was Rs 11.50 per piece, the DEPB benefit was Rs 2.30 (20 per cent) per piece. "In 2000, a value cap of Rs 55 per kg was introduced and this represented the value of the plastic and not the medical item as the equivalent worked out to 0.60 per cent DEPB on the finished product."

However, later the DGFT had reviewed the situation and offered an alternative of 20 per cent DEPB on Indian branded exports, on similar lines as that provided by the Chinese Government for `Made in China' products.

The current average price is Rs 7.75 per piece and given the current situation, manufacturers are left with no choice but to increase price by 15 to 20 per cent, which the customer is unwilling to accept. Maintaining the price would result in 15 per cent to 20 per cent loss of profits, he pointed out, speaking on behalf of the industry.

Send this article to Friends by E-Mail

Stories in this Section
Dumping duty mooted on Vit A


Parliament okay for Budget
Fiscal devolution still a major issue: Naidu
$315-m IBRD loan for Kerala, Mizoram
Sharjah free zone woos Indian cos
Rule of origin problems with US -- India for bilateral solutions
State as super venture capitalist
Petroleum Regulatory Bill has arm's length clause
`Krishna-Godavari ONGC project making rapid strides'
Drug, cosmetic rules amended
IEA suggests merger of energy ministries
BHEL in talks to market power saving device
Boom time for water tankers in twin cities
NGRI gets funds for water project
Ire over `unfair deal' for cigarette tobacco
Brand scheme scrapping irks medical devices industry
TN Chamber seeks tax relief
Bangalore to have DNA profiling centre
HPCL or BPCL the `real target' for Iffco-Kribhco
Bharat Bhari may sell entire holding in Braithwaite Burn
TN: Bill to ban strikes introduced
Kerala: Speaker's attitude resented
Meet on public governance to examine issues
Print and Pack 2002 expo
For a fair deal
PRSI to organise lecture
Bangalore Engagements
Reaching Ooty — an uphill task


The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | The Sportstar | Frontline | Home |

Copyright © 2002, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line